297 related articles for article (PubMed ID: 17000776)
1. Breast cancer metastasis suppressor 1 functions as a corepressor by enhancing histone deacetylase 1-mediated deacetylation of RelA/p65 and promoting apoptosis.
Liu Y; Smith PW; Jones DR
Mol Cell Biol; 2006 Dec; 26(23):8683-96. PubMed ID: 17000776
[TBL] [Abstract][Full Text] [Related]
2. Phosphorylation of RelA/p65 promotes DNMT-1 recruitment to chromatin and represses transcription of the tumor metastasis suppressor gene BRMS1.
Liu Y; Mayo MW; Nagji AS; Smith PW; Ramsey CS; Li D; Jones DR
Oncogene; 2012 Mar; 31(9):1143-54. PubMed ID: 21765477
[TBL] [Abstract][Full Text] [Related]
3. IkappaB kinase alpha-mediated derepression of SMRT potentiates acetylation of RelA/p65 by p300.
Hoberg JE; Popko AE; Ramsey CS; Mayo MW
Mol Cell Biol; 2006 Jan; 26(2):457-71. PubMed ID: 16382138
[TBL] [Abstract][Full Text] [Related]
4. BRMS1 contributes to the negative regulation of uPA gene expression through recruitment of HDAC1 to the NF-kappaB binding site of the uPA promoter.
Cicek M; Fukuyama R; Cicek MS; Sizemore S; Welch DR; Sizemore N; Casey G
Clin Exp Metastasis; 2009; 26(3):229-37. PubMed ID: 19165610
[TBL] [Abstract][Full Text] [Related]
5. The p65 (RelA) subunit of NF-kappaB interacts with the histone deacetylase (HDAC) corepressors HDAC1 and HDAC2 to negatively regulate gene expression.
Ashburner BP; Westerheide SD; Baldwin AS
Mol Cell Biol; 2001 Oct; 21(20):7065-77. PubMed ID: 11564889
[TBL] [Abstract][Full Text] [Related]
6. Breast cancer metastasis suppressor 1 (BRMS1) inhibits osteopontin transcription by abrogating NF-kappaB activation.
Samant RS; Clark DW; Fillmore RA; Cicek M; Metge BJ; Chandramouli KH; Chambers AF; Casey G; Welch DR; Shevde LA
Mol Cancer; 2007 Jan; 6():6. PubMed ID: 17227585
[TBL] [Abstract][Full Text] [Related]
7. Loss of BRMS1 promotes a mesenchymal phenotype through NF-κB-dependent regulation of Twist1.
Liu Y; Mayo MW; Xiao A; Hall EH; Amin EB; Kadota K; Adusumilli PS; Jones DR
Mol Cell Biol; 2015 Jan; 35(1):303-17. PubMed ID: 25368381
[TBL] [Abstract][Full Text] [Related]
8. Exchange of a nuclear corepressor between NF-kappaB and CREB mediates inhibition of phosphoenolpyruvate carboxykinase transcription by NF-kappaB.
Yan JH; Gao ZG; Ye JP; Weng JP
Chin Med J (Engl); 2010 Jan; 123(2):221-6. PubMed ID: 20137375
[TBL] [Abstract][Full Text] [Related]
9. Histone Deacetylase Inhibitor RGFP109 Overcomes Temozolomide Resistance by Blocking NF-κB-Dependent Transcription in Glioblastoma Cell Lines.
Li ZY; Li QZ; Chen L; Chen BD; Wang B; Zhang XJ; Li WP
Neurochem Res; 2016 Dec; 41(12):3192-3205. PubMed ID: 27632183
[TBL] [Abstract][Full Text] [Related]
10. Benzyl isothiocyanate-mediated inhibition of histone deacetylase leads to NF-kappaB turnoff in human pancreatic carcinoma cells.
Batra S; Sahu RP; Kandala PK; Srivastava SK
Mol Cancer Ther; 2010 Jun; 9(6):1596-608. PubMed ID: 20484017
[TBL] [Abstract][Full Text] [Related]
11. Alterations of BRMS1-ARID4A interaction modify gene expression but still suppress metastasis in human breast cancer cells.
Hurst DR; Xie Y; Vaidya KS; Mehta A; Moore BP; Accavitti-Loper MA; Samant RS; Saxena R; Silveira AC; Welch DR
J Biol Chem; 2008 Mar; 283(12):7438-44. PubMed ID: 18211900
[TBL] [Abstract][Full Text] [Related]
12. Disruption of IkappaB kinase (IKK)-mediated RelA serine 536 phosphorylation sensitizes human multiple myeloma cells to histone deacetylase (HDAC) inhibitors.
Dai Y; Chen S; Wang L; Pei XY; Funk VL; Kramer LB; Dent P; Grant S
J Biol Chem; 2011 Sep; 286(39):34036-50. PubMed ID: 21816815
[TBL] [Abstract][Full Text] [Related]
13. New molecular bridge between RelA/p65 and NF-κB target genes via histone acetyltransferase TIP60 cofactor.
Kim JW; Jang SM; Kim CH; An JH; Kang EJ; Choi KH
J Biol Chem; 2012 Mar; 287(10):7780-91. PubMed ID: 22249179
[TBL] [Abstract][Full Text] [Related]
14. BRMS1 inhibits expression of NF-kappaB subunit p65, uPA and OPN in ovarian cancer cells.
Sheng XJ; Zhou DM; Liu Q; Lou SY; Song QY; Zhou YQ
Eur J Gynaecol Oncol; 2014; 35(3):236-42. PubMed ID: 24984534
[TBL] [Abstract][Full Text] [Related]
15. Proenkephalin assists stress-activated apoptosis through transcriptional repression of NF-kappaB- and p53-regulated gene targets.
McTavish N; Copeland LA; Saville MK; Perkins ND; Spruce BA
Cell Death Differ; 2007 Sep; 14(9):1700-10. PubMed ID: 17599100
[TBL] [Abstract][Full Text] [Related]
16. PIAS3 suppresses NF-kappaB-mediated transcription by interacting with the p65/RelA subunit.
Jang HD; Yoon K; Shin YJ; Kim J; Lee SY
J Biol Chem; 2004 Jun; 279(23):24873-80. PubMed ID: 15140884
[TBL] [Abstract][Full Text] [Related]
17. Zac1 is a histone acetylation-regulated NF-κB suppressor that mediates histone deacetylase inhibitor-induced apoptosis.
Shu G; Tang Y; Zhou Y; Wang C; Song JG
Cell Death Differ; 2011 Dec; 18(12):1825-35. PubMed ID: 21546906
[TBL] [Abstract][Full Text] [Related]
18. Protein kinase Cdelta activates RelA/p65 and nuclear factor-kappaB signaling in response to tumor necrosis factor-alpha.
Lu ZG; Liu H; Yamaguchi T; Miki Y; Yoshida K
Cancer Res; 2009 Jul; 69(14):5927-35. PubMed ID: 19549902
[TBL] [Abstract][Full Text] [Related]
19. Selective repression of YKL-40 by NF-kappaB in glioma cell lines involves recruitment of histone deacetylase-1 and -2.
Bhat KP; Pelloski CE; Zhang Y; Kim SH; deLaCruz C; Rehli M; Aldape KD
FEBS Lett; 2008 Sep; 582(21-22):3193-200. PubMed ID: 18708058
[TBL] [Abstract][Full Text] [Related]
20. Blockade of histone deacetylase inhibitor-induced RelA/p65 acetylation and NF-kappaB activation potentiates apoptosis in leukemia cells through a process mediated by oxidative damage, XIAP downregulation, and c-Jun N-terminal kinase 1 activation.
Dai Y; Rahmani M; Dent P; Grant S
Mol Cell Biol; 2005 Jul; 25(13):5429-44. PubMed ID: 15964800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
